(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ADUX, GREENYARD, and KEYWARE TECH..

Financial Asset	Price	Change	Updated (EST)
ADUX (ADUX.PA)	1.43	8.33%	2024-04-05 12:45:12
GREENYARD (GREEN.BR)	5.50	8.27%	2024-04-05 12:20:05
KEYWARE TECH. (KEYW.BR)	0.90	7.83%	2024-04-05 12:20:33
HYDROGENPRO (HYPRO.OL)	14.20	7.41%	2024-04-05 12:40:33
AKWEL (AKW.PA)	15.24	6.57%	2024-04-05 12:45:27
SAS AB (SASNO.OL)	0.03	6.5%	2024-04-05 12:42:54
VOW (VOW.OL)	7.22	6.49%	2024-04-05 12:44:24
AFFLUENT MEDICAL (AFME.PA)	1.82	6.43%	2024-04-05 12:45:19
ATEME (ATEME.PA)	5.46	6.23%	2024-04-05 12:46:05
MAREL (MAREL.AS)	3.40	4.94%	2024-04-05 12:02:54

The three biggest losers today are HOFSETH BIOCARE, XIOR, and MITHRA.

Financial Asset	Price	Change	Updated (EST)
HOFSETH BIOCARE (HBC.OL)	2.01	-6.94%	2024-04-05 12:40:31
XIOR (XIOR.BR)	26.45	-5.54%	2024-04-05 12:22:15
MITHRA (MITRA.BR)	0.23	-5.05%	2024-04-05 12:20:45
NORWEGIAN AIR SHUT (NAS.OL)	16.38	-4.38%	2024-04-05 12:41:44
CRAYON GROUP HOLD (CRAYN.OL)	73.15	-4.38%	2024-04-05 12:25:41
IBA (IBAB.BR)	13.18	-3.94%	2024-04-05 12:20:13
NEW SOURCES ENERGY (NSE.AS)	0.03	-3.85%	2024-04-05 12:03:08
AUREA (AURE.PA)	4.76	-3.84%	2024-04-05 12:46:15
ENSURGE MICROPOWER (ENSU.OL)	1.40	-3.79%	2024-04-05 12:26:05
ABIONYX PHARMA (ABNX.PA)	1.07	-3.77%	2024-04-05 12:44:49

Winners today

1. ADUX (ADUX.PA)

8.33% Price Change

AdUX SA provides advertising services in France, Belgium, Italy, Spain, Germany, the Netherlands, and internationally. It provides non-intrusive advertising, in-content advertising, brand content, and geomarketing services. The company was founded in 1996 and is headquartered in Paris, France.

CAC 40 ended the session with ADUX jumping 8.33% to €1.43 on Friday, after five consecutive sessions in a row of gains. CAC 40 dropped 1.11% to €8,061.31, following the last session’s downward trend on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, ADUX has a trailing twelve months EPS of €0.72.

PE Ratio

ADUX has a trailing twelve months price to earnings ratio of 1.99. Meaning, the purchaser of the share is investing €1.99 for every euro of annual earnings.

More news about ADUX.

2. GREENYARD (GREEN.BR)

8.27% Price Change

Greenyard NV supplies fresh, frozen, and prepared fruit and vegetables in Germany, the Netherlands, Belgium, the United Kingdom, France, the rest of Europe, and internationally. The company operates through Fresh and Long Fresh segments. The Fresh segment markets and supplies fresh fruit and vegetables, flowers and plants, and fresh produce. The Long Fresh segment processes freshly harvested fruits and vegetables into frozen food products; and offers freshly preserved fruit, vegetables, and other ambient food products, as well as ready-made products, such as soups, sauces, dips, and pasta dishes. The company was formerly known as Greenyard Foods NV and changed its name to Greenyard NV in September 2016. Greenyard NV was founded in 1965 and is based in Sint-Katelijne-Waver, Belgium.

BEL 20 ended the session with GREENYARD rising 8.27% to €5.50 on Friday while BEL 20 dropped 0.98% to €3,834.33.

Earnings Per Share

As for profitability, GREENYARD has a trailing twelve months EPS of €0.16.

PE Ratio

GREENYARD has a trailing twelve months price to earnings ratio of 34.38. Meaning, the purchaser of the share is investing €34.38 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.87%.

Yearly Top and Bottom Value

GREENYARD’s stock is valued at €5.50 at 22:40 EST, way below its 52-week high of €7.10 and way higher than its 52-week low of €5.00.

Moving Average

GREENYARD’s value is above its 50-day moving average of €5.34 and under its 200-day moving average of €5.98.

More news about GREENYARD.

3. KEYWARE TECH. (KEYW.BR)

7.83% Price Change

Keyware Technologies NV, an independent fintech company, provides electronic payment solutions in Belgium. It offers payment transaction software for banks and financial institutions, tokenization software, instalment payment solutions, and ordering and payment app software; and payment processing and management services, as well as rents and sells payment terminals. The company was incorporated in 1996 and is headquartered in Zaventem, Belgium.

BEL 20 ended the session with KEYWARE TECH. rising 7.83% to €0.90 on Friday, following the last session’s downward trend. BEL 20 dropped 0.98% to €3,834.33, after two sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, KEYWARE TECH. has a trailing twelve months EPS of €0.05.

PE Ratio

KEYWARE TECH. has a trailing twelve months price to earnings ratio of 17.9. Meaning, the purchaser of the share is investing €17.9 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.71%.

Moving Average

KEYWARE TECH.’s worth is under its 50-day moving average of €0.92 and under its 200-day moving average of €0.93.

Revenue Growth

Year-on-year quarterly revenue growth grew by 27.9%, now sitting on 23.97M for the twelve trailing months.

More news about KEYWARE TECH..

4. HYDROGENPRO (HYPRO.OL)

7.41% Price Change

HydrogenPro ASA designs and delivers hydrogen technology and systems in Norway, Europe, the United States, and the Asia Pacific. The company provides high-pressure alkaline electrolyzers. It serves refinery/decarbonization, fertilizer/ammonia, steel production, power to gas, synthetic aviation fuel, and balancing the grid markets. HydrogenPro ASA was incorporated in 2013 and is headquartered in Porsgrunn, Norway.

Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO rising 7.41% to €14.20 on Friday while Oslo Børs Benchmark Index_GI rose 0.14% to €1,351.50.

Earnings Per Share

As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-1.09.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.13%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HYDROGENPRO’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

HYDROGENPRO’s stock is valued at kr14.20 at 22:40 EST, way under its 52-week high of kr33.60 and way higher than its 52-week low of kr9.40.

More news about HYDROGENPRO.

5. AKWEL (AKW.PA)

6.57% Price Change

Akwel SA manufactures automotive and heavy goods vehicle components in France and internationally. It offers fluid management, mechanisms, and structural parts for electric vehicles. The company's products include body pipes, flow regulation valves, anti-return valves, pulsation dampeners or temperature, and pressure sensors; air distributors, turbo air intake and output pipes and exchangers, exhaust gas recirculation pipes, and cylinder head covers, as well as a range of solutions for cooling and combining. It also offers electronic management of hardware, software, transfer, storage, reheating, and pumping systems; and manages washer systems, including storage, pumping, transfer, and jet. The company was formerly known as MGI Coutier SA and changed its name to AKWEL in June 2018. The company was founded in 1972 and is based in Champfromier, France. Akwel SA operates as a subsidiary of Coutier Junior Company.

CAC 40 ended the session with AKWEL jumping 6.57% to €15.24 on Friday while CAC 40 dropped 1.11% to €8,061.31.

Earnings Per Share

As for profitability, AKWEL has a trailing twelve months EPS of €1.06.

PE Ratio

AKWEL has a trailing twelve months price to earnings ratio of 14.38. Meaning, the purchaser of the share is investing €14.38 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.73%.

Volume

Today’s last reported volume for AKWEL is 13095 which is 155.41% above its average volume of 5127.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 1.03B for the twelve trailing months.

Moving Average

AKWEL’s worth is above its 50-day moving average of €15.04 and above its 200-day moving average of €14.64.

Yearly Top and Bottom Value

AKWEL’s stock is valued at €15.24 at 22:40 EST, way below its 52-week high of €18.24 and way above its 52-week low of €12.80.

More news about AKWEL.

6. SAS AB (SASNO.OL)

6.5% Price Change

SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 134 aircraft, including 16 long-haul aircraft, 87 short-haul aircraft, and 31 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Oslo Børs Benchmark Index_GI ended the session with SAS AB rising 6.5% to €0.03 on Friday while Oslo Børs Benchmark Index_GI jumped 0.14% to €1,351.50.

Earnings Per Share

As for profitability, SAS AB has a trailing twelve months EPS of kr-0.62.

Revenue Growth

Year-on-year quarterly revenue growth grew by 13%, now sitting on 43.07B for the twelve trailing months.

Volatility

SAS AB’s last week, last month’s, and last quarter’s current intraday variation average was a negative 7.33%, a negative 3.54%, and a positive 8.77%.

SAS AB’s highest amplitude of average volatility was 7.33% (last week), 7.32% (last month), and 8.77% (last quarter).

Volume

Today’s last reported volume for SAS AB is 68299600 which is 40.7% above its average volume of 48539700.

More news about SAS AB.

7. VOW (VOW.OL)

6.49% Price Change

Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. It operates in three segments: Projects Cruise, Aftersales, and Landbased. The Projects Cruise segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables; chemicals; and tailor-made service and maintenance programs. The Landbased segment offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. This segment also develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. The company serves cruise, aquaculture, and landbased industries, as well as utilities. It has a strategic partnership agreement with Repsol, S.A. to explore applications and solutions to produce clean and renewable energy for CO2 emission reduction; European Tyre Enterprise Ltd. to develop a modularised and industrial solutions, and value chain to turn end-of-life tires into raw material and renewable energy; GRTgaz to produce a demo plant built to confirm that CO2 neutral pyrolysis gas can replace fossil gas in the European gas grid; SAS IMPROVE to develop technological solutions for the farm to fork valorisation of future proteins; and Imtech Steri's Biosteam to offer a range of ingredient sterilisation solutions and services. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with VOW rising 6.49% to €7.22 on Friday while Oslo Børs Benchmark Index_GI rose 0.14% to €1,351.50.

Earnings Per Share

As for profitability, VOW has a trailing twelve months EPS of kr0.05.

PE Ratio

VOW has a trailing twelve months price to earnings ratio of 144.4. Meaning, the purchaser of the share is investing kr144.4 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -33.1%.

Yearly Top and Bottom Value

VOW’s stock is valued at kr7.22 at 22:40 EST, way under its 52-week high of kr17.80 and way above its 52-week low of kr5.40.

More news about VOW.

8. AFFLUENT MEDICAL (AFME.PA)

6.43% Price Change

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

CAC 40 ended the session with AFFLUENT MEDICAL rising 6.43% to €1.82 on Friday, after two consecutive sessions in a row of losses. CAC 40 slid 1.11% to €8,061.31, following the last session’s downward trend on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.65.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.37%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AFFLUENT MEDICAL’s stock is considered to be overbought (>=80).

More news about AFFLUENT MEDICAL.

9. ATEME (ATEME.PA)

6.23% Price Change

ATEME SA, together with its subsidiaries, provides electronic and computer devices and instruments worldwide. The company offers various solutions, such as TITAN Live, a software-based live video compression for the converged headend; TITAN File, a video transcoding software; TITAN Mux, a multi-function software stream processing solution; KYRION CM5000e, an ultra-low latency encoder; TITAN Edge encoder; TITAN Edge decoder; TITAN Edge gateway; and KYRION DR5000, an ultra-low latency integrated receiver decoder. It also provides NEA-CDN, an OTT scale service solution; NEA-DVR; NEA-Live for immersive viewing experience; NEA-Composer, a dynamic Ad insertion and linear origination solution; PILOT Media, a cloud native media supply chain solution; and PILOT Manager, a cloud native management system. The company serves content providers, service providers, and streaming platforms. ATEME SA was incorporated in 1991 and is headquartered in Vélizy-Villacoublay, France.

CAC 40 ended the session with ATEME rising 6.23% to €5.46 on Friday, after two consecutive sessions in a row of gains. CAC 40 fell 1.11% to €8,061.31, following the last session’s downward trend on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, ATEME has a trailing twelve months EPS of €-0.28.

Volatility

ATEME’s last week, last month’s, and last quarter’s current intraday variation average was 5.31%, 1.15%, and 2.51%.

ATEME’s highest amplitude of average volatility was 5.46% (last week), 2.20% (last month), and 2.51% (last quarter).

More news about ATEME.

10. MAREL (MAREL.AS)

4.94% Price Change

Marel hf. develops, manufactures, distributes, and sells solutions, software, and services to food processing industries in Europe, the Middle East, Africa, the Americas, Asia, and Oceania. The company operates through four segments: Poultry Processing; Meat Processing; Fish Processing; and Plant, Pet, and Feed. The company's Poultry Processing segment offers automated in-line solutions, software, and services for all stages of processing broilers, turkeys, and ducks. Its Meat Processing segment supplies primary, secondary, and further processing equipment, systems, software, and services of pork, beef, veal, and sheep. The company's Fish Processing segment offers equipment, systems, software, and services for processing salmon and whitefish, both farmed and wild, on-board, and ashore. Its Plant, Pet, and Feed segment provides solutions and services to the pet food, plant-based protein, and aqua feed markets. The company also provides software assurance agreement, customer support, training, process consultancy, preventive maintenance, consumable packages, calibration, inspection, critical parts, and repair and exchange services, as well as upgrade kits. Marel hf. was founded in 1977 and is based in Garðabær, Iceland.

AEX-Index ended the session with MAREL jumping 4.94% to €3.40 on Friday while AEX-Index fell 0.4% to €880.63.

Earnings Per Share

As for profitability, MAREL has a trailing twelve months EPS of €0.04.

PE Ratio

MAREL has a trailing twelve months price to earnings ratio of 85. Meaning, the purchaser of the share is investing €85 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MAREL’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 8.4%, now sitting on 1.72B for the twelve trailing months.

More news about MAREL.

Losers Today

1. HOFSETH BIOCARE (HBC.OL)

-6.94% Price Change

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol, joint, eye, brain, and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome, and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2009 and is headquartered in Ålesund, Norway.

Oslo Børs Benchmark Index_GI ended the session with HOFSETH BIOCARE falling 6.94% to €2.01 on Friday while Oslo Børs Benchmark Index_GI rose 0.14% to €1,351.50.

Earnings Per Share

As for profitability, HOFSETH BIOCARE has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112.79%.

Volume

Today’s last reported volume for HOFSETH BIOCARE is 166398 which is 26.08% above its average volume of 131977.

Volatility

HOFSETH BIOCARE’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.34%, a negative 0.35%, and a positive 2.64%.

HOFSETH BIOCARE’s highest amplitude of average volatility was 3.99% (last week), 3.30% (last month), and 2.64% (last quarter).

Moving Average

HOFSETH BIOCARE’s worth is way under its 50-day moving average of kr2.40 and way below its 200-day moving average of kr2.73.

Earnings Before Interest, Taxes, Depreciation, and Amortization

HOFSETH BIOCARE’s EBITDA is -104.85.

More news about HOFSETH BIOCARE.

2. XIOR (XIOR.BR)

-5.54% Price Change

Xior Student Housing NV is the first Belgian public regulated real estate company (RREC) specialising in the student housing segment in Belgium, the Netherlands, Spain, Portugal, Germany, Poland, Denmark and Sweden. Within this property segment, Xior Student Housing offers a variety of accommodation, ranging from rooms with shared facilities to en-suite rooms and fully equipped studios. Since 2007, as owner-operator, Xior Student Housing has built high-quality, reliable student accommodation for students looking for the ideal place to study, live and relax. A place with that little bit extra, where every student immediately feels at home. Xior Student Housing has been accredited as a public RREC under Belgian law since 24 November 2015. Xior Student Housing's shares have been listed on Euronext Brussels (XIOR) since 11 December 2015. On 31 December 2023, Xior Student Housing held a property portfolio worth approximately EUR 3.21 billion.

BEL 20 ended the session with XIOR falling 5.54% to €26.45 on Friday, following the last session’s upward trend. BEL 20 dropped 0.98% to €3,834.33, after two successive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, XIOR has a trailing twelve months EPS of €-0.74.

More news about XIOR.

3. MITHRA (MITRA.BR)

-5.05% Price Change

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.

BEL 20 ended the session with MITHRA sliding 5.05% to €0.23 on Friday while BEL 20 slid 0.98% to €3,834.33.

Earnings Per Share

As for profitability, MITHRA has a trailing twelve months EPS of €-1.41.

Moving Average

MITHRA’s worth is way under its 50-day moving average of €0.75 and way below its 200-day moving average of €1.47.

More news about MITHRA.

4. NORWEGIAN AIR SHUT (NAS.OL)

-4.38% Price Change

Norwegian Air Shuttle ASA, together with its subsidiaries, provides air travel services in Norway and internationally. It operates short haul point to point domestic and cross border flights services. It is also involved in aircraft financing, leasing, and ownership activities; and cargo activities. It operates a fleet of 70 aircrafts. Norwegian Air Shuttle ASA was founded in 1993 and is headquartered in Fornebu, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORWEGIAN AIR SHUT falling 4.38% to €16.38 on Friday while Oslo Børs Benchmark Index_GI jumped 0.14% to €1,351.50.

Earnings Per Share

As for profitability, NORWEGIAN AIR SHUT has a trailing twelve months EPS of kr1.3.

PE Ratio

NORWEGIAN AIR SHUT has a trailing twelve months price to earnings ratio of 12.6. Meaning, the purchaser of the share is investing kr12.6 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.82%.

More news about NORWEGIAN AIR SHUT.

5. CRAYON GROUP HOLD (CRAYN.OL)

-4.38% Price Change

Crayon Group Holding ASA, together with its subsidiaries, operates as an IT consultancy company. It operates through Software & Cloud Direct, Software & Cloud Channel, Software & Cloud Economics, and Consulting segments. The company provides assess and migrate services, including cloud migration assessment, maturity assessment, cloud infrastructure advisory and migration, cloud POC, cloud tenant migration, cloud connectivity, modern workplace migration, cloud security assessment, professional cybersecurity, and cloud identity; govern and optimize services comprising IT governance, license optimization, software and cloud economics, and SAM tool; operate and support services, such as modern workplace adoption, compliance recording, software and cloud advisory service desk, cloud managed services, AWS managed, and crayon managed security posture services; and data platform and AI solutions services, comprising AI solution, language technologies, data platform, visual quality inspection, and machine learning operation services. It also offers software and IT asset management services; and consulting services related to infrastructure consulting, cloud migration and deployment, bespoke software deployment and follow-up of applications. The company has operations in the Nordics, Europe, the Asia-Pacific, the Middle East and Africa, and the United States. Crayon Group Holding ASA was founded in 2002 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with CRAYON GROUP HOLD dropping 4.38% to €73.15 on Friday while Oslo Børs Benchmark Index_GI jumped 0.14% to €1,351.50.

Earnings Per Share

As for profitability, CRAYON GROUP HOLD has a trailing twelve months EPS of kr-1.29.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.15%.

Sales Growth

CRAYON GROUP HOLD’s sales growth is 33.6% for the present quarter and negative 55.6% for the next.

Volatility

CRAYON GROUP HOLD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.47%, a positive 0.17%, and a positive 2.08%.

CRAYON GROUP HOLD’s highest amplitude of average volatility was 1.51% (last week), 1.30% (last month), and 2.08% (last quarter).

Volume

Today’s last reported volume for CRAYON GROUP HOLD is 387361 which is 38.73% below its average volume of 632233.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 4660% and 200%, respectively.

More news about CRAYON GROUP HOLD.

6. IBA (IBAB.BR)

-3.94% Price Change

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

BEL 20 ended the session with IBA dropping 3.94% to €13.18 on Friday, after three successive sessions in a row of gains. BEL 20 dropped 0.98% to €3,834.33, after two consecutive sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, IBA has a trailing twelve months EPS of €-0.31.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.17%.

More news about IBA.

7. NEW SOURCES ENERGY (NSE.AS)

-3.85% Price Change

AEX-Index ended the session with NEW SOURCES ENERGY falling 3.85% to €0.03 on Friday while AEX-Index slid 0.4% to €880.63.

More news about NEW SOURCES ENERGY.

8. AUREA (AURE.PA)

-3.84% Price Change

Aurea SA engages in the recycling of black motor oil in France. The company is also involved in the manufacturing of remold tires from used tires and recycling rigid PVC. It recycles plastics and packaging products; refines and recycles aluminum; recycles copper and produces copper alloys; and treats and recycles zinc, lead, and cadmium. In addition, the comany engages in the treatment and decontamination of mercury waste. The company was formerly known as AUER and changed its name to Aurea SA in 1988. Aurea SA is based in Paris, France.

CAC 40 ended the session with AUREA sliding 3.84% to €4.76 on Friday, after two successive sessions in a row of gains. CAC 40 dropped 1.11% to €8,061.31, following the last session’s downward trend on what was an all-around negative trend exchanging session today.

Earnings Per Share

As for profitability, AUREA has a trailing twelve months EPS of €0.74.

PE Ratio

AUREA has a trailing twelve months price to earnings ratio of 6.43. Meaning, the purchaser of the share is investing €6.43 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AUREA’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for AUREA is 1132 which is 12.19% above its average volume of 1009.

Volatility

AUREA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.88%, a negative 0.17%, and a positive 1.90%.

AUREA’s highest amplitude of average volatility was 1.29% (last week), 1.90% (last month), and 1.90% (last quarter).

More news about AUREA.

9. ENSURGE MICROPOWER (ENSU.OL)

-3.79% Price Change

Ensurge Micropower ASA manufactures and sells ultrathin energy storage solutions for wearable devices, connected sensors, and other applications. Its solid-state lithium battery technology enables it to produce rechargeable batteries. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER sliding 3.79% to €1.40 on Friday while Oslo Børs Benchmark Index_GI jumped 0.14% to €1,351.50.

Earnings Per Share

As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-0.51.

Volume

Today’s last reported volume for ENSURGE MICROPOWER is 3243170 which is 78.66% below its average volume of 15203000.

More news about ENSURGE MICROPOWER.

10. ABIONYX PHARMA (ABNX.PA)

-3.77% Price Change

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. It develops CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.

CAC 40 ended the session with ABIONYX PHARMA falling 3.77% to €1.07 on Friday, after five sequential sessions in a row of gains. CAC 40 fell 1.11% to €8,061.31, following the last session’s downward trend on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.11%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABIONYX PHARMA’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

ABIONYX PHARMA’s stock is valued at €1.07 at 22:40 EST, way under its 52-week high of €2.38 and higher than its 52-week low of €1.05.

Revenue Growth

Year-on-year quarterly revenue growth declined by 19.1%, now sitting on 4.75M for the twelve trailing months.

Moving Average

ABIONYX PHARMA’s value is way below its 50-day moving average of €1.27 and way under its 200-day moving average of €1.27.

More news about ABIONYX PHARMA.

Stay up to date with our winners and losers daily report